litlas
ログインアカウント作成

Alan F. List

1982–2025 年に発表

別表記
ALAN F. LIST
144
論文数
26,801
被引用数
89
h 指数
144
i10 指数

被引用数

Alan F. List の年別被引用数1948 年: 被引用 1 件1983 年: 被引用 2 件1984 年: 被引用 3 件1985 年: 被引用 3 件1986 年: 被引用 5 件1987 年: 被引用 2 件1988 年: 被引用 5 件1989 年: 被引用 12 件1990 年: 被引用 11 件1991 年: 被引用 11 件1992 年: 被引用 13 件1993 年: 被引用 18 件1994 年: 被引用 25 件1995 年: 被引用 25 件1996 年: 被引用 29 件1997 年: 被引用 35 件1998 年: 被引用 42 件1999 年: 被引用 56 件2000 年: 被引用 54 件2001 年: 被引用 56 件2002 年: 被引用 71 件2003 年: 被引用 91 件2004 年: 被引用 56 件2005 年: 被引用 76 件2006 年: 被引用 89 件2007 年: 被引用 102 件2008 年: 被引用 110 件2009 年: 被引用 149 件2010 年: 被引用 185 件2011 年: 被引用 190 件2012 年: 被引用 205 件2013 年: 被引用 282 件2014 年: 被引用 220 件2015 年: 被引用 231 件2016 年: 被引用 205 件2017 年: 被引用 196 件2018 年: 被引用 243 件2019 年: 被引用 679 件2020 年: 被引用 692 件2021 年: 被引用 836 件2022 年: 被引用 652 件2023 年: 被引用 446 件2024 年: 被引用 586 件2025 年: 被引用 284 件2026 年: 被引用 2 件1949〜1982 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,627 件、この内訳の 32.1%ドイツ: 引用元論文 614 件、この内訳の 7.5%中国: 引用元論文 501 件、この内訳の 6.1%イタリア: 引用元論文 494 件、この内訳の 6%イギリス: 引用元論文 491 件、この内訳の 6%フランス: 引用元論文 452 件、この内訳の 5.5%スペイン: 引用元論文 256 件、この内訳の 3.1%カナダ: 引用元論文 253 件、この内訳の 3.1%日本: 引用元論文 240 件、この内訳の 2.9%オランダ: 引用元論文 239 件、この内訳の 2.9%オーストラリア: 引用元論文 200 件、この内訳の 2.5%スイス: 引用元論文 151 件、この内訳の 1.9%
0%32.1%その他 20.4%

機関

分野

  • Medicine69.9%
  • Biochemistry, Genetics and Molecular Biology20.7%
  • Immunology and Microbiology7%
  • Materials Science1%
  • Neuroscience0.3%
  • Computer Science0.2%
  • その他0.9%

トピック

  • Acute Myeloid Leukemia Research15.2%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment5.3%
  • Hematopoietic Stem Cell Transplantation3.9%
  • Epigenetics and DNA Methylation3.6%
  • Histone Deacetylase Inhibitors Research3%
  • Immune Cell Function and Interaction2.7%
  • その他66.3%

共著者

全論文

検索で開く
  1. Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes

    著者: David A. Sallman, Amy E. DeZern, Guillermo Garcia‐Manero, David P. Steensma, Gail J. Roboz, Mikkael A. Sekeres, Thomas Cluzeau, Kendra Sweet, Amy F. McLemore, Kathy L. McGraw, John Puskas, Ling Zhang, Jiqiang Yao, Qianxing Mo, Lisa Nardelli, Najla H. Al Ali, Eric Padron, Greg Korbel, Eyal C. Attar, Hagop M. Kantarjian, Jeffrey E. Lancet, Pierre Fenaux, Alan F. List, Rami S. Komrokji - Journal of Clinical Oncology 2021 被引用: 460

  2. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

    著者: Pierre Fenaux, Ghulam J. Mufti, Eva Hellström‐Lindberg, Valeria Santini, Carlo Finelli, Aristoteles Giagounidis, Robert Schoch, Norbert Gattermann, Guillermo Sanz, Alan F. List, Steven D. Gore, John F. Seymour, John M. Bennett, John C. Byrd, Jay T. Backstrom, Linda Zimmerman, David R. McKenzie, C.L. Beach, Lewis R. Silverman - The Lancet Oncology 2009 被引用: 2,640

  3. Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

    著者: Pierre Fenaux, Uwe Platzbecker, Ghulam J. Mufti, Guillermo Garcia‐Manero, Rena Buckstein, Valeria Santini, María Díez‐Campelo, Carlo Finelli, Mario Cazzola, Osman İlhan, Mikkael A. Sekeres, José Falantes, Beatriz Arrizabalaga, Flavia Salvi, Valentina Giai, Paresh Vyas, David Bowen, Dominik Selleslag, Amy E. DeZern, Joseph G. Jurcic, Ulrich Germing, Katharina S. Götze, Bruno Quesnel, Odile Beyne‐Rauzy, Thomas Cluzeau, Maria-Teresa Voso, Dominiek Mazure, Edo Vellenga, Peter L. Greenberg, Eva Hellström-Lindberg, Amer M. Zeidan, Lionel Adès, Amit Verma, Michael R. Savona, Abderrahmane Laadem, Aziz Benzohra, Jennie Zhang, Anita Rampersad, Diana Dunshee, Peter G. Linde, Matthew L. Sherman, Rami S. Komrokji, Alan F. List - New England Journal of Medicine 2020 被引用: 537

  4. The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype

    著者: Ashley A. Basiorka, Kathy L. McGraw, Erika A. Eksioglu, Xianghong Chen, Joseph Johnson, Ling Zhang, Qing Zhang, Brittany Irvine, Thomas Cluzeau, David A. Sallman, Eric Padron, Rami S. Komrokji, Lubomir Sokol, Rebecca C. Coll, Avril A. B. Robertson, Matthew A. Cooper, John L. Cleveland, Luke O'neill, Sheng Wei, Alan F. List - Blood 2016 被引用: 346

  5. Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study

    著者: Nancy Gillis, Markus Ball, Qing Zhang, Zhenjun Ma, YuLong Zhao, Sean Yoder, Maria E. Balasis, Tania Mesa, David A. Sallman, Jeffrey E. Lancet, Rami S. Komrokji, Alan F. List, Howard L. McLeod, Melissa Alsina, Rachid Baz, Kenneth H. Shain, Dana E. Rollison, Eric Padron - The Lancet Oncology 2016 被引用: 313

  6. TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype

    著者: David A. Sallman, Amy F. McLemore, Amy L. Aldrich, Rami S. Komrokji, Kathy L. McGraw, Abhishek Dhawan, Susan Geyer, Hsin‐An Hou, Erika A. Eksioglu, Amy Sullivan, Sarah Warren, Kyle J. MacBeth, Manja Meggendorfer, Torsten Haferlach, Steffen Boettcher, Benjamin L. Ebert, Najla H. Al Ali, Jeffrey E. Lancet, John L. Cleveland, Eric Padron, Alan F. List - Blood 2020 被引用: 188

  7. TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

    著者: Detlef Haase, Kristen E. Stevenson, Donna Neuberg, Jaroslaw P. Maciejewski, Aziz Nazha, Mikkael A. Sekeres, Benjamin L. Ebert, Guillermo Garcia‐Manero, Claudia Haferlach, Torsten Haferlach, Wolfgang Kern, Seishi Ogawa, Yasunobu Nagata, Kenichi Yoshida, Timothy A. Graubert, Matthew J. Walter, Alan F. List, Rami S. Komrokji, Eric Padron, David A. Sallman, Elli Papaemmanuil, Peter J. Campbell, Michael R. Savona, Adam C. Seegmiller, Lionel Adès, Pierre Fenaux, Lee‐Yung Shih, David Bowen, Michael J. Groves, Sudhir Tauro, Michaëla Fontenay, Olivier Kosmider, Michal Bar‐Natan, David P. Steensma, Richard M. Stone, Michael Heuser, Felicitas Thol, Mario Cazzola, Luca Malcovati, Aly Karsan, Christina Ganster, Eva Hellström‐Lindberg, Jacqueline Boultwood, Andrea Pellagatti, Valeria Santini, Lynn Quek, Paresh Vyas, Heinz Tüchler, Peter L. Greenberg, Rafael Bejar - Leukemia 2019 被引用: 259

  8. The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes

    著者: David A. Sallman, Alan F. List - Blood 2019 被引用: 273

  9. Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion

    著者: Alan F. List, Gordon W. Dewald, John M. Bennett, Aristoteles Giagounidis, Azra Raza, Eric J. Feldman, Bayard L. Powell, Peter L. Greenberg, Deborah A. Thomas, Richard M. Stone, Craig B. Reeder, Kenton Wride, John Patin, M. Schmidt, Jerome B. Zeldis, Robert Knight - New England Journal of Medicine 2006 被引用: 1,317

  10. Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes

    著者: David A. Sallman, Rami S. Komrokji, Christine Vaupel, Thomas Cluzeau, Susan Geyer, Kathy L. McGraw, Najla H. Al Ali, Jeffrey E. Lancet, Matthew J. McGinniss, Shareef Nahas, Alexander Smith, Austin Kulasekararaj, G J Mufti, Alan F. List, Jeff Hall, Eric Padron - Leukemia 2015 被引用: 231

  11. Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes

    著者: Grace Ward, Robert Dalton, Benjamin S. Meyer, Amy F. McLemore, Amy L. Aldrich, Nghi B. Lam, Alexis Onimus, Nicole D. Vincelette, Thu Le Trinh, Xianghong Chen, Alexandra Calescibetta, Sean Christiansen, Hsin‐An Hou, Joseph Johnson, Kenneth L. Wright, Eric Padron, Erika A. Eksioglu, Alan F. List - International Journal of Molecular Sciences 2023 被引用: 39

  12. Induction of myelodysplasia by myeloid-derived suppressor cells

    著者: Xianghong Chen, Erika A. Eksioglu, Junmin Zhou, Ling Zhang, Julie Y. Djeu, Nicole Fortenbery, Pearlie K. Epling‐Burnette, Sandra van Bijnen, Harry Dolstra, John P. Cannon, Je‐In Youn, Sarah S. Donatelli, Dahui Qin, Théo de Witte, Jianguo Tao, Huaquan Wang, Pingyan Cheng, Dmitry I. Gabrilovich, Alan F. List, Sheng Wei - Journal of Clinical Investigation 2013 被引用: 312

  13. Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117

    著者: Mikkael A. Sekeres, Megan Othus, Alan F. List, Olatoyosi Odenike, Richard M. Stone, Steven D. Gore, Mark R. Litzow, Rena Buckstein, Min Fang, Diane Roulston, Clara D. Bloomfield, Anna Moseley, Aziz Nazha, Yanming Zhang, Mario R. Velasco, Rakesh Gaur, Ehab Atallah, Eyal C. Attar, Elina K. Cook, Alyssa Cull, Michael J. Rauh, Frederick R. Appelbaum, Harry P. Erba - Journal of Clinical Oncology 2017 被引用: 238

  14. A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions

    著者: Tae–Hoon Shin, Yifan Zhou, Shirley Chen, Stefan Cordes, Max Z. Grice, Xing Fan, Byung‐Chul Lee, Aisha AlJanahi, So Gun Hong, Kelli L. Vaughan, Julie A. Mattison, Steven G. Kohama, Margarete A. Fabre, Naoya Uchida, Selami Demirci, Marcus Alexandre Finzi Corat, Jean‐Yves Métais, Katherine R. Calvo, Manuel Buscarlet, Hannah Natanson, Kathy L. McGraw, Alan F. List, Lambert Busque, John F. Tisdale, George S. Vassiliou, Kyung–Rok Yu, Cynthia E. Dunbar - Blood 2022 被引用: 39

  15. Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

    著者: Pierre Fenaux, Ghulam J. Mufti, Eva Hellström‐Lindberg, Valeria Santini, Norbert Gattermann, Ulrich Germing, Guillermo Sanz, Alan F. List, Steven D. Gore, John F. Seymour, Hervé Dombret, Jay T. Backstrom, Linda Zimmerman, David R. McKenzie, C.L. Beach, Lewis R. Silverman - Journal of Clinical Oncology 2009 被引用: 958

  16. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia

    著者: Andrés Jerez, Michael J. Clemente, Hideki Makishima, Hanna Koskela, Francis LeBlanc, Kwok Peng Ng, Thomas L. Olson, Bartlomiej Przychodzen, Manuel Afable, Inés Gómez‐Seguí, Kathryn M Guinta, Lisa Durkin, Eric D. Hsi, Kathy L. McGraw, Dan Zhang, Marcin W. Włodarski, Kimmo Porkka, Mikkael A. Sekeres, Alan F. List, Satu Mustjoki, Thomas P. Loughran, Jaroslaw P. Maciejewski - Blood 2012 被引用: 418

  17. Biological drivers of clinical phenotype in myelofibrosis

    著者: John Mascarenhas, Hélène F.E. Gleitz, Helen T. Chifotides, Claire Harrison, Srđan Verstovšek, Alessandro M. Vannucchi, Raajit K. Rampal, Jean‐Jacques Kiladjian, William Vainchenker, Ronald Hoffman, Rebekka K. Schneider, Alan F. List - Leukemia 2022 被引用: 59

  18. Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuation

    著者: Andrew Kuykendall, Savan Shah, Chetasi Talati, Najla Al Ali, Kendra Sweet, Eric Padron, David A. Sallman, Jeffrey E. Lancet, Alan F. List, Kenneth S. Zuckerman, Rami S. Komrokji - Annals of Hematology 2017 被引用: 129

  19. Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype

    著者: David A. Sallman, Thomas Cluzeau, Ashley A. Basiorka, Alan F. List - Frontiers in Oncology 2016 被引用: 110

  20. Efficacy of Lenalidomide in Myelodysplastic Syndromes

    著者: Alan F. List, S. Kurtin, Denise J. Roe, Andrew J. Buresh, Daruka Mahadevan, Deborah Fuchs, Lisa M. Rimsza, Ruth Heaton, Robert Knight, Jerome B. Zeldis - New England Journal of Medicine 2005 被引用: 876

  21. Applying Synthetic Lethality for the Selective Targeting of Cancer

    著者: Donal P. McLornan, Alan F. List, Ghulam J. Mufti - New England Journal of Medicine 2014 被引用: 242

  22. Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations

    著者: Britta Will, Li Zhou, Thomas O. Vogler, Susanna Ben-Neriah, Carolina Schinke, Roni Tamari, Yiting Yu, Tushar D. Bhagat, Sanchari Bhattacharyya, Laura Barreyro, Christoph Heuck, Yonkai Mo, Samir Parekh, Christine M. McMahon, Andrea Pellagatti, Jacqueline Boultwood, Cristina Montagna, Lewis B. Silverman, Jaroslaw P. Maciejewski, John M. Greally, B. Hilda Ye, Alan F. List, Christian Steidl, Ulrich Steidl, Amit Verma - Blood 2012 被引用: 239

  23. Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial

    著者: Rami S. Komrokji, Guillermo Garcia‐Manero, Lionel Adès, Thomas Prébet, David P. Steensma, Joseph G. Jurcic, Mikkael A. Sekeres, Jesús G. Berdeja, Michael R. Savona, Odile Beyne‐Rauzy, Aspasia Stamatoullas, Amy E. DeZern, Jacques Delaunay, Gautam Borthakur, Robert M. Rifkin, Thomas E. Boyd, A. Laadem, Bond Vo, Jennie Zhang, Marie Puccio-Pick, Kenneth M. Attie, Pierre Fenaux, Alan F. List - The Lancet Haematology 2018 被引用: 119

  24. Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma

    著者: Pingyan Cheng, Xianghong Chen, Robert Dalton, Alexandra Calescibetta, Tina So, Danielle L. Gilvary, Grace Ward, Victoria Smith, Sterling Eckard, Judith A. Fox, Jeanmarie Guenot, Joseph Markowitz, John L. Cleveland, Kenneth L. Wright, Alan F. List, Sheng Wei, Erika A. Eksioglu - Molecular Therapy 2022 被引用: 43